Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 07, 2020

SELL
$76.7 - $88.45 $460,200 - $530,700
-6,000 Closed
0 $0
Q3 2019

Nov 07, 2019

SELL
$81.4 - $89.78 $21,326 - $23,522
-262 Reduced 4.18%
6,000 $525,000
Q2 2019

Jul 25, 2019

SELL
$73.44 - $82.41 $27,172 - $30,491
-370 Reduced 5.58%
6,262 $513,000
Q1 2019

May 10, 2019

BUY
$64.48 - $81.31 $21,407 - $26,994
332 Added 5.27%
6,632 $509,000
Q3 2018

Nov 09, 2018

SELL
$70.71 - $77.75 $4,384 - $4,820
-62 Reduced 0.97%
6,300 $412,000
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $403,541 - $479,758
6,362 New
6,362 $448,000
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $375,582 - $403,697
-6,112 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $363,664 - $394,896
6,112
6,112 $384,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Hcr Wealth Advisors Portfolio

Follow Hcr Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hcr Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Hcr Wealth Advisors with notifications on news.